l e t t e r s Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors 1, 2 . Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various mature somatic cell types by brief expression of the induced pluripotent stem cell (iPSC) reprogramming factors Oct4, Sox2, Klf4 and c-Myc (OSKM) followed by cell expansion in media that promote lineage differentiation [3] [4] [5] [6] .
Here we test this method using genetic lineage tracing for expression of endogenous Nanog and Oct4 and for X chromosome reactivation, as these events mark acquisition of pluripotency. We show that the vast majority of reprogrammed cardiomyocytes or neural stem cells obtained from mouse fibroblasts by OSKM-induced 'transdifferentiation' pass through a transient pluripotent state, and that their derivation is molecularly coupled to iPSC formation mechanisms. Our findings underscore the importance of defining trajectories during cell reprogramming by various methods.
Somatic cell transdifferentiation involves ectopic expression of lineage master regulators that induce conversion into a different somatic cell type without passing through a pluripotent configuration. For example, expression of C/EBPα converts Pro-B cells into macrophage-like cells 1, 7 . Recently, a new approach to somatic transdifferentiation, called OSKM-mediated transdifferentiation (OSKM-TD), has been described in which Yamanaka's four original pluripotency reprogramming factors 8 are briefly expressed for periods as short as 3-10 d to induce an intermediate, partially reprogrammed and presumably nonpluripotent 'plastic' state [3] [4] [5] [6] . Next, lineage-specifying media that lack conventional pluripotency-promoting cytokines, such as leukemia inhibitory factor (LIF), are provided to shift these intermediate cells toward a desired somatic cell fate without their ever becoming pluripotent [3] [4] [5] [6] . The authors of these studies supported their conclusion that OSKM-TD circumvents pluripotency in several ways [3] [4] [5] . Brief OSKM induction of <10 d was deemed insufficient to yield iPSCs. Culture conditions, particularly the absence of LIF and the presence of JAK1 smallmolecule inhibitors to block Stat3 signaling, were designed to prevent acquisition of pluripotency. However, lineage-tracing tools that could unequivocally determine whether the cells attained pluripotency were not used. Thus, it remains unclear whether somatic cells produced by OSKM-TD transdifferentiate or, alternatively, go through a transient state of induced pluripotency and then differentiate to a somatic lineage according to the media conditions applied. Addressing this question is fundamental to understanding mechanisms of cellular reprogramming and to evaluating the safety of cells reprogrammed by this technique in potential clinical applications.
Our interest in this issue arose from our observation that Nanog-GFP + iPSCs appear at low efficiency during reprogramming with different doxycycline (Dox)-inducible OSKM transgenic systems 2, 9, 10 after as few as 3 d of Dox induction in conditions of 15% FBS, 5% KSR and LIF (leukemia inhibitory factor) ( Fig. 1a) . Furthermore, when we induced OSKM transgene expression 2, 9, 10 with Dox (doxycycline) in Oct4-GFP secondary reporter fibroblast cells using cardiogenic or neural stem cell (NSC) growth conditions instead of conventional LIF-containing pluripotency conditions, we obtained GFP + embryonic stem cell (ESC)-like colonies and 'hybrid' colonies with Oct4-GFP + cells in the center and, on the edges, no Oct4-GFP + cells and clear signs of neuronal differentiation ( Supplementary  Fig. 1a-c) . These results emphasized the need to exclude the possibility that iPSCs may form rapidly under suboptimal reprogramming conditions and may be a source of 'transdifferentiated' cells generated by OSKM-TD approaches 3, 4 .
We next engineered a system to track transient acquisition of pluripotency during in vitro reprogramming. Authors of previous OSKM-TD studies argued that the lack of Nanog reactivation in the bulk of reprogramming cultures 3, 4 proved that the cells did not become pluripotent. Thus, we designed a genetic tracing system for reactivation of endogenous Nanog, which occurs at the late stages of iPSC formation 3, 4, 11, 12 . In our system, transient activation of Nanog is monitored by permanent tdTomato fluorescence, indicating that pluripotency was achieved, even if only temporarily. For this purpose transient acquisition of pluripotency during somatic cell transdifferentiation with iPsC reprogramming factors l e t t e r s we first mated the Rosa26 M2rtTA/m.Col1a OSKM +/+ reprogrammable mouse strain 9 with Rosa26 LoxP-stop-LoxP tdTomato +/+ reporter mice and derived and validated mouse ESC (mESC) lines from embryonic day E3.5 blastocysts that are heterozygous for the triple knock-in alleles: Rosa26 M2rtTA +/− , Rosa26 LoxP-Stop-LoxP tdTomato +/− and m.Col1a-TetO-OSKM +/− (Fig. 1b) . Next, we generated a bacterial artificial chromosome (BAC)-recombineered Nanog-CreER targeting construct, which introduces a knock-in tamoxifen-inducible CreER cassette under the control of the endogenous Nanog promoter ( Fig. 1c and Supplementary Fig. 2a ). The quadruple-knock-in mESCs were microinjected into host blastocysts to generate chimeric animals from which transgenic fibroblasts were extracted for experimental analysis (Fig. 1b) .
We validated the sensitivity and specificity of this system. mESCs reactivated tdTomato rapidly after 48 h of 4-hydroxytamoxifen (4OHT) induction (95-100% of ESC colonies), and no fluorescence was detected in mESCs passaged over extended periods of time in the absence of 4OHT (Supplementary Fig. 2b) . NCAM + -sorted cells from early embryoid bodies did not activate the tdTomato reporter after 4OHT treatment indicating that Nanog-CreER was not active in nascent neuroectoderm or mesoderm (Supplementary Fig. 3 ). Mouse embryonic fibroblasts (MEFs) expanded with or without Dox in the absence of 4OHT did not show any reactivation of tdTomato, further indicating the specificity of the system and excluding leakiness during expansion or reprogramming. The fidelity of the reporter was evaluated by reprogramming the transgenic MEFs to pluripotency, by adding Dox and 4OHT to the medium and withdrawing both molecules at days 6 and 10. Adding 4OHT alone did not produce any colonies whereas adding Dox alone produced mESC-like colonies, all of which were tdTomato negative ( Fig. 1d and Supplementary Fig. 2c ). mESC-like colonies formed in each of the conditions at days 6 and 10 (48 colonies for each group) were randomly subcloned and grown for another 5-6 d, and the presence of tdTomato + clones was assessed as a percentage of the total number of developed and validated Doxindependent iPSC clones. We found the fidelity of our system to be ~85% and ~92% for iPSCs obtained after 6 and 10 d of Dox + 4OHT Figure 1 Lineage tracing for endogenous Nanog reactivation during reprogramming. (a) MEFs from three different secondary reprogramming systems, all carrying a Nanog-GFP knock-in reporter for pluripotency, were subjected to Dox-induced reprogramming. Dox was applied for the indicated times and then withdrawn. iPSC formation was evaluated at day 11 without passaging. Error bars, s.e.m. ± mean of biological triplicates (one out of two representative experiments is shown). (b) Scheme illustrating generation of quadruple knock-in-allele reporter in reprogrammable MEFs, used for either OSKM-iPSC or OSKM-TD reprogramming. (c) Nanog-CreER knock-in targeting strategy. (d) Reprogrammable Nanog-CreER MEFs were subjected to iPSC reprogramming in the presence of Dox, 4OHT or both, which were withdrawn at day 6 or 10 as indicated. 48 colonies were randomly subcloned and validated as iPSCs (Nanog, SSEA1 and AP staining) from each condition and time point, and then scored for the presence of tdTomato + signal. Bar plot showing percentage of tdTomato + iPSCs clones obtained indicates the sensitivity of the system. Error bars, s.e.m. ± mean of biological duplicates (one out of three representative experiments is shown).
npg l e t t e r s induction, respectively (Fig. 1d) . The <100% sensitivity might be explained by limitations of the Nanog knock-in allele activation, biallelic expression of Nanog, or a reflection of a true biological outcome, given that Nanog activity can be dispensable during iPSC generation 12 . Nevertheless, these results validate the ability of the system to document acquisition of pluripotency during iPSC reprogramming with high specificity.
Next, we applied the Nanog tracing system and reporter-engineered MEFs to previously reported OSKM-TD experiments on converting mouse fibroblasts into NSCs 3 (TD-NSC) and cardiomyocytes (TD-CM) 4 . The published protocols were meticulously followed ( Fig. 2a) , including the use of conditions without LIF or feeder cells.
The TD-NSC protocol 3 generated Sox1 + NSC colonies that could be subcloned and expanded as stable NSC lines ( Fig. 2b and Supplementary Fig. 4 ), as previously shown. RNA-seq analysis confirmed the transcriptional similarity of TD-NSCs to NSCs derived from primary embryos, and their difference from MEFs, ESCs and iPSCs ( Supplementary Fig. 5a ). Notably, ~82% of Sox1 + TD-NSC colonies were tdTomato + , indicating acquisition of pluripotency during their conversion from MEFs ( Fig. 2c and Supplementary Figs. 5b, 6 and 7a,b ). npg l e t t e r s Similarly, the TD-CM protocol ( Fig. 2d) yielded TD-CMs that expressed early and late cardiomyocytes markers (myosin, cardiac troponin T), many of which showed beating rhythmicity ( Fig. 2e,f and Supplementary Fig. 5b-c and Supplementary Videos 1 and 2) . Approximately 93% of myosin + TD-CM colonies, and within each colony the majority of cells, were tdTomato + , indicating transient acquisition of pluripotency ( Fig. 2e-g and Supplementary  Figs. 5b,c and 7b,c) .
It is well established that an additional late and specific hallmark of acquisition of naive pluripotency during reprogramming to iPSCs is reactivation of the silenced X chromosome. Subsequent differentiation of iPSCs involves random X inactivation 13 . To determine whether X chromosome reactivation occurs in OSKM-TD, we crossed female Rosa26 M2rtTA +/+ /m.Col1a-TetO-OSKM +/+ mice 9 with male mice carrying an X-linked GFP reporter transgene 14 , and purified GFP − tail tip fibroblasts from female offspring; all GFP − reprogrammable cells carried the GFP transgene on the inactive X chromosome (Fig. 2h) . Notably, GFP fluorescence was identified in >90% of TD-NSC and TD-CM colonies (Fig. 2h) , and in 100% of iPSC colonies obtained. Reprogramming of female-derived XGFP − Pro-B lymphocytes into macrophage-like cells by C/EBPα overexpression 15 did not yield any GFP + /Mac1 + colonies (Fig. 2h) , thus excluding promiscuous, nonspecific X-chromosome reactivation in the transdifferentiation protocols applied.
Finally, we used MEFs derived from mice carrying an Oct4-CreER knock-in reporter and a Rosa26 mTomato/mGFP (mT/mG) reporter cassette; in these cells mTomato expression is switched to EGFP expression upon Oct4 locus reactivation in the presence of 4OHT (Supplementary Fig. 8a) 16 . Repeating OSKM-TD protocols l e t t e r s with either polycistronic lentiviral vectors or with individual Moloney leukemia retroviruses encoding OSKM (Fig. 2i) showed that 100% of Sox1 + TD-NSC and myosin + TD-CM colonies lost mTomato expression and became GFP + , marking endogenous Oct4 reactivation during their reprogramming process ( Fig. 2i and  Supplementary Fig. 8b-d) .
The higher efficiency of Oct4 reactivation (100%) compared with Nanog and X-chromosome reactivation that we detected may be explained by the fact that Oct4 is expressed in all states of pluripotency (primed, metastable and naive), whereas Nanog and X-chromosome reactivation are more stringent markers observed only in naive pluripotency 11, 17 . Alternatively, endogenous Oct4 reactivation in isolation may not unequivocally indicate the reacquisition of pluripotency 18 . Nevertheless, the Oct4, Nanog and X-chromosome lineage tracing results collectively corroborate the conclusion that the vast majority of mouse OSKM-TD cells pass through a pluripotent state before transitioning toward overt somatic differentiation. Acquisition of pluripotency in these secondary Nanog-CreER cells was not the result of higher levels of OSKM mRNA compared with those in ESCs or during reprogramming to iPSCs, and was demonstrated with several different OSKM delivery methods and reporters ( Supplementary Fig. 9a,b) .
The above results indicate that the majority of OSKM-TD cells pass through a transient Nanog + pluripotent state before differentiating into various somatic linages according to the culture conditions applied. To validate and evaluate features of this transient pluripotent state, we sorted Nanog-CreER-reprogramed cells at the early end point of OSKM induction of the TD protocol (day 6 for TD-NSC and day 9 for TD-CM protocol) ( Fig. 3a and Supplementary Fig. 10a,b) . Sorted tdTomato + cells were immediately subjected to various functional and molecular tests of pluripotency.
Both day 6-and day 9-sorted tdTomato + cells obtained early during TD-NSC and TD-CM protocols, respectively, generated teratomas in vivo, with mature differentiation toward all three germ layers ( Fig. 3b and Supplementary Fig. 10c ). tdTomato + -sorted cells at both time points, but not pluripotent primed EpiSCs (epiblast stem cells) or somatic MEFs, contributed to mouse chimeric embryos after microinjection into host E3.5 blastocysts (Supplementary Fig. 10d,e) .
RNA-seq analysis of sorted day 6 tdTomato + TD-NSC protocol derived cells validated reactivation of bona fide pluripotency genes, including Nanog, Sall4, Nr5A2, Cdh1, Utf1 and Epcam ( Fig. 3c and  Supplementary Fig. 11 ). qPCR and western blot analysis for endogenous reactivation of several pluripotency factors ( Supplementary  Fig. 12a ), further validated these results. The transcriptional profiles of these cells consistently clustered with those of iPSCs and ESCs and apart from those of established primary NSCs, TD-NSCs and MEFs (Supplementary Fig. 12b,c) . As expected, they were not fully identical to those of established ESCs and iPSCs as these early-isolated tdTomato + cells were reprogrammed in sub-optimal conditions and could not consolidate their pluripotency program under optimal naive pluripotency conditions and long-term passaging.
Global chromatin accessibility measured by an assay for transposase-accessible chromatin followed by sequencing (ATAC-seq) 19 showed reactivation of enhancer and promoter regions of key bona fide pluripotency genes in day 9 tdTomato + -sorted cells from the TD-CM protocol, similar to what is observed in ESC and iPSC lines ( Fig. 3d  and Supplementary Figs. 13 and 14) . Although the OSKM-TD protocol does not use 2i/LIF conditions, genome-wide DNA methylation assessment by whole-genome bisulfite sequencing showed significant global reduction in DNA methylation levels in tdTomato + -sorted cells toward what is typically measured in ground-state naive 2i/LIF murine pluripotent cells (Fig. 3e) . This result documents transient global DNA demethylation during reprogramming by OSKM without applying 2i and may be worth further investigation.
We next explored the functional role of endogenous Nanog reactivation in OSKM-TD. Endogenous Nanog reactivation has been shown to synergistically boost iPSC reprogramming by OSKM 20 . We compared conversion of Nanog −/− and Nanog +/+ MEFs into iPSCs and OSKM-TD cells 20 . Nanog −/− mESCs can be expanded in N2B27 2i/LIF/15% KSR conditions while maintaining their pluripotency 21, 22 (Supplementary Fig. 15a) , and therefore we used these conditions for iPSC generation. Reprogramming of Nanog −/− and Nanog +/+ MEFs to pluripotency was done by OSKM transduction, and both yielded validated pluripotent iPSCs (Supplementary Fig. 15b-d) . However, the reprogramming efficiency of Nanog −/− MEFs was only 10% that of Nanog +/+ MEFs at day 6 after OSKM induction, and only 45% at day 10 ( Fig. 3f and Supplementary Figs. 15e and 16) . Next, Nanog −/− and Nanog +/+ MEFs were used in OSKM-TD protocols for generating TD-NSCs and TD-CMs. Transient reactivation of pluripotency markers such as Utf1 or SSEA1 was evident in Nanog −/− MEFs in both of these protocols by the end of the OSKM induction steps ( Supplementary  Figs. 17 and 18) . Upon completion of the reprogramming process, the Nanog −/− cells yielded validated TD-NSCs and TD-CMs (Supplementary Fig. 19 ) at an efficiency of only ~25% compared with Nanog +/+ cells ( Fig. 3f and Supplementary Figs. 15e and 16a) . Collectively, these results show that endogenous Nanog reactivation is functionally coupled to OSKM-TD efficiency, and at an equivalent robustness to that observed during OSKM-iPSC formation.
Finally, OSKM-TD protocols make use of media devoid of LIF or with added JAK1 inhibitor, which blocks Stat3 pathway signaling, under the assumption that these conditions completely prevent the formation of pluripotent iPSCs 3, 4 . Given that OSKM transgenes have been found sufficient to support induction and expansion of pluripotent cells (ESCs and iPSCs) from nonpermissive mouse strains (i.e., nonobese diabetic mice) in suboptimal growth conditions lacking ERK1/2 small-molecule inhibitors 23 , we wondered whether they could also stabilize mouse iPSCs in suboptimal conditions lacking exogenous LIF. To address this question, we reprogrammed Nanog-CreER reporter MEFs to pluripotency in LIF-free N2B27 medium with added JAK1 inhibitor ( Supplementary Fig. 20a,b) . Transgene-dependent iPSCs were derived, expanded and shown to be pluripotent by staining for alkaline phosphatase, SSEA1 and Nanog and by the potential to form mature teratomas ( Supplementary Fig. 20c,d) . These results corroborate previous findings that Stat3 signaling is dispensable for re-establishing pluripotency 24 , and that simply blocking Stat3 signaling does not prevent acquisition of pluripotency when OSKM transgenes are provided, as the latter can substitute for the requirement for exogenous LIF to induce and maintain pluripotency 23 .
Conversion of cell fate in vitro and in vivo holds great potential for regenerative medicine. There may be different routes of reprogramming to achieve a given cell type 25 , and it is important to understand their technical and functional advantages and disadvantages and the molecular pathways and trajectories of each method 26, 27 . Although our study of OSKM-TD shows that the vast majority of the cells are reprogrammed to pluripotency and then rapidly differentiate according to the media used, we cannot exclude the possibility that some cells do transdifferentiate without passing through a pluripotent state. From the perspective of potential applications of OSKM-TD, both the advantages and disadvantages associated with iPSC generation will likely be relevant. It will also be useful to conduct similar studies on OSKM-TD of human cells 5, 6, 28 . Finally, considering the continual discovery of factors, inhibitors and cytokines that induce and maintain npg Mouse embryo micromanipulation. Pluripotent ESCs, day-9 iPSCs, EpiSCs or Nanog-CreER (days 6 or 9) tdTomato + cells were injected into BDF2 (F2 mating of siblings of female C57BL/6 and male DBA/2 F1 mice) diploid blastocysts (ten cells per embryo, unless specified otherwise), harvested from hormone-primed BDF1 6-week-old females. MEF cells constitutively labeled with tdTomato were used as negative controls (three MEF cells were injected per blastocyst). All cells were subjected to the same sorting conditions and were immediately used for microinjections. Microinjection into BDF2 E3.5 blastocysts placed in M2 medium under mineral oil was done by a flat-tip microinjection pipette. After microinjection, blastocysts were returned to KSOM media (Zenith) and kept at 37 °C until transferred to recipient females. Ten to 15 injected blastocysts were transferred to each uterine horn of 2.5-d post-coitum pseudo-pregnant females. 129 EpiSCs, constitutively labeled with tdTomato exogenous transgene, were treated with ROCK inhibitor 48 h before harvesting with Accutase (Sigma-Aldrich), to increased survival yield. The latter experiments were approved by the Weizmann Institute IACUC (00330111-2). Animals were not randomized and investigators were not blinded for this study. No animals were excluded from any analysis throughout this study. Accurate mouse embryos and/or animal group size is indicated in Supplementary Figures 10c,e. Viral production. For primary cell reprogramming, ~3 × 10 6 293T cells in a 10-cm culture dish were transfected with a solution made of 770 µl DMEM (Invitrogen) together with 50 µl of TransIT-LT1, pPAX (3.5 µg), pMDG (1.5 µg) and 5 µg of the lentiviral target plasmid (FUW-M2rtTA, FUW-TetO-STEMCCA-OKSM, FUW-TetO-OSKM). Viral supernatant was harvested 48 and 72 h after transfection, filtered through 0.45-µm sterile filters (Nalgene) and added freshly to the reprogrammed cells. Murine stem cell virus C/EBPα retrovirus stocks were prepared by transient transfection of Phoenix-Eco cells using Fugene (Roche), and supernatants were harvested 48 h later and filtered. Pro-B cell expansion on OP9 cells and transduction with C/EBPα was conducted as previously described 10 .
Immunostaining. Nanog-CreER iPSCs in LIF-free N2B27 medium with supplemented JAK1 inhibitor and Dox, and Nanog −/− iPSCs were cultured on glass cover slips (13 mm, 1.5 H; Marienfeld, 0117530), washed three times with PBS and fixed with 4% paraformaldehyde for 10 min at room temperature. Cells were then permeabilized and blocked in 0.1% Triton, 0.1% Tween and 5% FBS in PBS for 15 min at room temperature. Primary antibodies were incubated for 2 h at room temperature and then washed with 0.1% Tween and 1% FBS in PBS three times. Next, cells were incubated with secondary antibody for 1 h at room temperature, washed and counterstained with DAPI, mounted with Shandon Immu-Mount (Thermo Scientific) and imaged. All secondary antibodies were diluted 1:200.
For staining of transdifferentiated NSCs, cardiomyocytes and intermediate cells, all cells were reprogrammed in 6-well tissue culture plates, fixed and stained in the tissue culture wells. The following antibodies were used: Microscopy and image analysis. Images were acquired with A1 Axioscope microscope (Carl Zeiss) equipped with DP73 camera (Olympus) or with Z1 Axioscope microscope (Carl Zeiss), using a 20X Plan-Apochromat objective (numerical aperture 0.4). All images were acquired in sequential mode. Images were processed with Zeiss Zenblue 2011 software (Carl Zeiss) and
Adobe Photoshop CS4. An in-house algorithm was developed and implemented in Matlab to process the images and analyze the percentage of tdTomato + /green-fluorescence + overlay area out of total green-fluorescence + area (Supplementary Figs. 5c and 7) . The algorithm consists of the following steps: (i) noise reduction using sliding median filter; (ii) creating a binary mask image per channel using a detection threshold defined as the overall image median value plus bias (defined as 10% of the dynamic range); all pixels with values above the threshold are "detected"; (iii) overlaying tdTomato + and green-fluorescence + mask images and calculating the percentage of tdTomato + & green-fluorescence + pixels out of all green-fluorescence + pixels.
Western blot analysis. Whole-cell protein extracts were isolated from wildtype Nanog +/+ , Nanog −/− mESCs, Nanog-CreER reporter MEFs and sorted day 6 tdTomato + intermediate cells. Blots were incubated with the following antibodies in 5% BSA/TBST: rabbit polyclonal Hsp90β antibody (Calbiochem CA1016, 1:5,000), rabbit monoclonal Gapdh antibody (Epitomics 2251-1, 1:5000), rabbit polyclonal Oct4 antibody clone H-134 (Santa Cruz SC9081, 1:1,000), rabbit polyclonal Sall4 antibody (abcam ab29112 1:1000) and rabbit polyclonal Nanog antibody (Bethyl A300-397A, 1:1,000). Secondary antibodies were horseradish peroxidase-linked goat anti-rabbit (1:10,000; Jackson). Blots were developed using ECL (Thermo Scientific). Figure 10c , sorted Nanog-CreER tdTomato + cells at day 6 and 9 of OSKM-TD protocols were injected subcutaneously into the flanks of immune-deficient nonobese diabetic severe combined immunodeficient gamma chain deficient (NSG) mice. Sorted ESCs were used as a positive control. For each time point, 2 × 10 5 -sorted tdTomato + cells were collected in 25× diluted Matrigel (BD Bioscience), and subsequently injected subcutaneously in NSG mice. Three animals were injected (on one side) per each group. After 4 weeks, all injected mice were euthanized and the tumor mass extracted, measured and fixed in 4% paraformaldehyde overnight. In Supplementary Figure 20 , Nanog-CreER iPSCs expanded in LIF-free N2B27 medium with supplemented JAK1 inhibitor and doxycycline and Nanog −/− iPSCs grown in N2B27 2i/LIF cell lines were expanded for over eight passages and injected (2 × 10 6 cells) subcutaneously into the flanks of NSG mice and dissected 4-6 weeks afterwards. Slides were prepared from the paraffin-embedded fixed tissue, which were next stained with H&E and inspected for representation of all three germ layers. Differentiation results were confirmed by a board-certified histopathologist.
Teratoma assay. In Supplementary
Alkaline phosphatase staining. Cells were grown on 6-well tissue culture plates and were washed three times with PBS and fixed with 4% paraformaldehyde for 2 min at room temperature. Alkaline phosphatase staining was performed according to the manufacturer's protocol (Millipore SCR004).
RNA sequencing and gene expression profiling analysis. RNA was extracted from Trizol pellets and used for RNA-seq by TruSeq RNA Sample Preparation Kit v2 (Illumina) according to the manufacturer's directions. DNA sequencing was conducted on Illumina HiSeq1500. Tophat software version 2.0.10 was used to align reads to mouse mm10 reference genome (UCSC, December 2011). Read counts per exon were calculated over all 628,052 exons in mm10 ensemble GTF (UCSC, December 2011), using bedtools coverage command (version 2.16.2). Exons annotated as protein coding, pseudogene or long noncoding (linc)RNA (n = 459,556) were selected for further analysis. Exon counts were normalized by the exon length in kbp and by million number of aligned reads per sample, to give RPKM (read-per-kilobase-per-million-reads) values. Gene expression was defined by the average expression level (RPKM) of all exons associated with a certain gene. Sample hierarchical clustering was done over primary brain-derived NSCs, MEFs, mESCs and two subclones of TD-NSCs (Supplementary Fig. 5a ); only exons with at least one RPKM call > 2 were selected, resulting in 371,807 exons corresponding to 19,755 genes. Additional hierarchical clustering was done over all samples ( Supplementary  Fig. 12c) ; only exons with at least one RPKM call > 2 were selected, resulting in 379,435 exons corresponding to 20,419 genes. Hierarchical clustering was carried out in both figures, using Matlab (version R2011b) clustergram command, with Spearman correlation as a distance metric, average linkage
